scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.YEXCR.2004.06.021 |
P698 | PubMed publication ID | 15383324 |
P2093 | author name string | Eric B Kmiec | |
Luciana Ferrara | |||
Hetal Parekh-Olmedo | |||
P2860 | cites work | Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity | Q28140338 |
Characterization of homologous recombination induced by replication inhibition in mammalian cells | Q28343741 | ||
Pathways of DNA double-strand break repair during the mammalian cell cycle | Q28608969 | ||
Homologous recombinational repair of DNA ensures mammalian chromosome stability | Q28646561 | ||
Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death | Q29614845 | ||
An efficient recombination system for chromosome engineering in Escherichia coli | Q29615038 | ||
The contribution of homologous recombination in preserving genome integrity in mammalian cells | Q33601052 | ||
A surfeit of RAD51-like genes? | Q33633019 | ||
Rad51p and Rad54p, but not Rad52p, elevate gene repair in Saccharomyces cerevisiae directed by modified single-stranded oligonucleotide vectors | Q33888510 | ||
Targeted single-base correction by RNA-DNA oligonucleotides | Q34085768 | ||
Different roles for nonhomologous end joining and homologous recombination following replication arrest in mammalian cells | Q34284545 | ||
Rescue of arrested replication forks by homologous recombination | Q34311622 | ||
Recombineering: a powerful new tool for mouse functional genomics | Q34389493 | ||
Genetic engineering using homologous recombination | Q34995474 | ||
Transcription affects formation and processing of intermediates in oligonucleotide-mediated gene alteration | Q35018060 | ||
The development and regulation of gene repair | Q35209965 | ||
Nuclease Activity of Saccharomyces cerevisiae Mre11 Functions in Targeted Nucleotide Alteration | Q36049800 | ||
Identification of factors influencing strand bias in oligonucleotide-mediated recombination in Escherichia coli | Q37370959 | ||
Differential expression of topoisomerase I and RAD52 protein in yeast reveals new facets of the mechanism of action of bisdioxopiperazine compounds | Q38273585 | ||
DNA topoisomerase poisons as antitumor drugs | Q38286727 | ||
Prospects for the therapeutic use of antigene oligonucleotides | Q38287378 | ||
Molecular dissection of interactions between Rad51 and members of the recombination-repair group | Q38305014 | ||
Cell cycle modulation of gene targeting by a triple helix-forming oligonucleotide. | Q38358463 | ||
DNA pairing is an important step in the process of targeted nucleotide exchange | Q39731423 | ||
Reduction of Ribonucleotides | Q39805408 | ||
International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents | Q40391405 | ||
The effect of hydroxyurea and trichostatin a on targeted nucleotide exchange in yeast and Mammalian cells | Q40594078 | ||
RAD51 is involved in repair of damage associated with DNA replication in mammalian cells | Q40653432 | ||
Defects in homologous recombination repair in mismatch-repair-deficient tumour cell lines | Q40709592 | ||
Functional correction of episomal mutations with short DNA fragments and RNA-DNA oligonucleotides. | Q40740212 | ||
Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53. | Q40753297 | ||
Decreased topoisomerase IIalpha expression confers increased resistance to ICRF-193 as well as VP-16 in mouse embryonic stem cells | Q40813729 | ||
Binding of double-strand breaks in DNA by human Rad52 protein | Q40956601 | ||
Antitopoisomerase drug action and resistance | Q41078123 | ||
Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II. | Q41104419 | ||
p53 protects from replication-associated DNA double-strand breaks in mammalian cells | Q44741925 | ||
Sequence-specific cleavage of double helical DNA by triple helix formation. | Q46000915 | ||
Gatekeepers of recombination | Q58323746 | ||
Heterogeneity of cancer cells from a single human colon carcinoma | Q71025411 | ||
A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines | Q73357711 | ||
Yeast cells expressing differential levels of human or yeast DNA topoisomerase II: a potent tool for identification and characterization of topoisomerase II-targeting antitumour agents | Q77408645 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | gene targeting | Q211083 |
P304 | page(s) | 170-179 | |
P577 | publication date | 2004-10-01 | |
P1433 | published in | Experimental Cell Research | Q1524289 |
P1476 | title | Enhanced oligonucleotide-directed gene targeting in mammalian cells following treatment with DNA damaging agents | |
P478 | volume | 300 |
Q33635829 | A 'Semi-Protected Oligonucleotide Recombination' Assay for DNA Mismatch Repair in vivo Suggests Different Modes of Repair for Lagging Strand Mismatches |
Q42278013 | A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells |
Q33432320 | A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repair |
Q40156233 | Camptothecin enhances the frequency of oligonucleotide-directed gene repair in mammalian cells by inducing DNA damage and activating homologous recombination |
Q41850053 | Combinatorial gene editing in mammalian cells using ssODNs and TALENs. |
Q39848054 | DNA breakage associated with targeted gene alteration directed by DNA oligonucleotides |
Q38209315 | Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells |
Q38349381 | Enhanced gene repair mediated by methyl-CpG-modified single-stranded oligonucleotides |
Q36091278 | Gene therapy progress and prospects: targeted gene repair |
Q26781566 | Genetic spell-checking: gene editing using single-stranded DNA oligonucleotides |
Q33850144 | Increased efficiency of oligonucleotide-mediated gene repair through slowing replication fork progression. |
Q36239465 | Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides |
Q33272502 | Manipulation of cell cycle progression can counteract the apparent loss of correction frequency following oligonucleotide-directed gene repair |
Q40206773 | Multiple roles for MSH2 in the repair of a deletion mutation directed by modified single-stranded oligonucleotides |
Q41812045 | Oligonucleotide delivery by nucleofection does not rescue the reduced proliferation phenotype of gene-edited cells |
Q26778792 | Oligonucleotide-directed mutagenesis for precision gene editing |
Q39821715 | Parameters of oligonucleotide-mediated gene modification in mouse ES cells |
Q37821231 | Progress and prospects: oligonucleotide-directed gene modification in mouse embryonic stem cells: a route to therapeutic application. |
Q40284701 | Recovery of cell cycle delay following targeted gene repair by oligonucleotides |
Q33270548 | Reduction of gene repair by selenomethionine with the use of single-stranded oligonucleotides |
Q33316832 | Simultaneous targeted exchange of two nucleotides by single-stranded oligonucleotides clusters within a region of about fourteen nucleotides |
Q40435624 | Site-specific base changes in the coding or promoter region of the human beta- and gamma-globin genes by single-stranded oligonucleotides |
Q40244305 | Targeted chromosomal gene modification in human cells by single-stranded oligodeoxynucleotides in the presence of a DNA double-strand break |
Q35215217 | The involvement of replication in single stranded oligonucleotide-mediated gene repair. |
Q28538328 | The position of DNA cleavage by TALENs and cell synchronization influences the frequency of gene editing directed by single-stranded oligonucleotides |
Search more.